CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Atrys Health SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Atrys Health SA
C/ Principe de Vergara 132, 1 piso
Phone: +34 934581561p:+34 934581561 MADRID, MAD  28002  Spain Ticker: ATRYATRY

Business Summary
Atrys Health SA, formerly Europath Biosciences SL, is Spain-based company primarily engaged in the predictive and personalized oncology therapies. It operates under Atrys brand name. Atrys is a clinical and translational research laboratory dedicated to the diagnosis, prognosis and treatment of cancer, including hematologic and solid malignancies. It has four areas of activity: Laboratory, Telemedicine, Radiotherapy, as well as Research and Development (R&D). The Company has its diagnostic laboratories and translational research in Barcelona and Granada, and offices in Madrid, Spain.
(Source: 10-K405)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board SantiagoDe Torres Sanahuja 1/1/2016 1/1/2016
Chief Executive Officer, Executive Director IsabelLozano Fernandez 1/1/2016 1/1/2016
Partner, Vice President - Genetics AlfonsoAlba 10/1/2020 10/1/2020
12 additional Officers and Directors records available in full report.

Business Names
Business Name
A2T
ATRY
Axismed Gestao Preventiva De Saude S.A.
9 additional Business Names available in full report.

General Information
Number of Employees: 2,084 (As of 6/30/2024)
Outstanding Shares: 75,936,954 (As of 6/30/2024)
Stock Exchange: MCE
Fax Number: +34 915776744


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024